GCMG · GCM Grosvenor

The thesis

GCM Grosvenor's fee-related earnings are growing and fundraising is accelerating, which supports a modestly better-than-even chance that the shares beat the S&P 500 over the next three months. The fourth-quarter report, expected around February 2027, shows whether full-year 2026 fundraising reaches the record $10.7 billion raised in 2025, as management said on 9 November 2026 it would "rival".

Fee-related earnings (FRE) are profit from management and advisory fees, before performance income. The company's third-quarter release of 9 November 2026 reported FRE up 15% from a year earlier, GAAP (US accounting standard) net income up 17% and adjusted net income up 20%. Earnings Whispers puts third-quarter FRE at about $54 million at a 47% margin, against 45% in the second quarter.

Fundraising was $2.7 billion in the third quarter, above the $2.3 billion raised in the second quarter and $1.5 billion in the first. Trailing twelve-month fundraising was about $10 billion, according to the earnings call as summarized by Earnings Whispers.

The market has credited the report. The shares closed at $13.45 on 9 November 2026 and $13.53 on 12 November 2026, against $12.66 on 6 November 2026. The 52-week high is the intraday $14.87 of 11 August 2026. JPMorgan (Neutral) set a target of $14.5 and Piper Sandler (Overweight) a target of $15 on 10 November 2026, both just above the current price.

Bullish and bearish views on GCM Grosvenor Inc.

The bull case on GCM Grosvenor Inc. (GCMG), in brief: fee earnings and margin both improved. The bear case: the backlog is shrinking.

Bull case

• Fee earnings and margin both improved. FRE rose 15% from a year earlier in the third quarter and the margin reached 47%, up from 44% in the first quarter and 45% in the second (company release 9 November 2026; Earnings Whispers).
• Fundraising is building through the year. Quarterly fundraising rose from $1.5 billion to $2.3 billion to $2.7 billion across 2026. Management expects full-year 2026 to rival 2025's $10.7 billion, which implies a large fourth quarter (earnings call, 9 November 2026).
• Adjusted profit beat estimates. Adjusted earnings per share were $0.22 against a $0.21 estimate, and revenue of $145.6 million against a $141.6 million estimate (news reports, 9 November 2026). Estimates differ by source: Earnings Whispers cited a $154.0 million revenue consensus.
• SpaceX is being turned into cash value. The firm sold more than $500 million of its SpaceX exposure in the third quarter and is still selling, with just over $3 billion of exposure left. Unrealized carry (accrued performance fees) reached a record $592 million, up from $493 million (Finviz and Earnings Whispers coverage of the call, 9 November 2026).
• Management is more confident on 2028. On the call, management said it now sees more upside than downside to its 2028 adjusted net income target (9 November 2026).
• Dividend continues. The board approved $0.12 per share, payable 15 December 2026 to holders of record on 1 December 2026, with $54.1 million left on the $255.0 million buyback authorization at 30 September 2026 (company release, 9 November 2026).

Bear case

• The backlog is shrinking. Contracted assets not yet paying fees fell to $8.7 billion from $9.7 billion in the second quarter, and have declined each quarter from $10 billion at the end of 2025 (Finviz coverage of the call, 9 November 2026).
• Private-markets fee growth is slowing. Private-markets management fee growth eased to 7% from about 10%. Management guided the fourth quarter to 7% to 9% growth from a year earlier (Finviz, 9 November 2026).
• Absolute-return fee growth is set to cool. Management guided fee growth in the absolute return strategies to the mid-teens, from 19% in the third quarter. The ARS multi-strategy composite fell 2% gross in the quarter (Finviz, 9 November 2026).
• Growth in reported FRE slowed. FRE grew 15% in the third quarter, after 21% in the second quarter at $50.3 million (company 8-K, 10 August 2026).
• Insiders have been sellers. SEC Form 4 filings show Chief Financial Officer Pamela Bentley selling 50,000 shares at an average of $12.59 on 15 September to 16 September 2026 under a pre-arranged plan, and Principal Accounting Officer Kathleen Sullivan selling 40,000 at an average of $13.16 on 2 September to 3 September 2026.
• Targets sit close to the price. JPMorgan's $14.5 and Piper Sandler's $15 targets, both published 10 November 2026, leave limited room above the $13.53 close of 12 November 2026.

Price setup

The shares closed at $13.53 on 12 November 2026, after $14.20 on 11 November 2026, $13.92 on 10 November 2026, $13.45 on 9 November 2026 and $12.66 on 6 November 2026. The last close is 9.0% below the 52-week high of $14.87 (intraday, 11 August 2026). The 52-week closing low was $9.45 on 27 March 2026.

On adjusted daily closes, the 50-day average was $12.90 and the 200-day average $11.80 as of 12 November 2026. The shares sit above both. The three-month change is −1.5%, measured from the adjusted close of 14 August 2026.

Supply is the main pressure on the shares. Insiders held 70.70% of Class A shares on 5 September 2026 (MarketBeat), leaving a thin float, and the Form 4 sales above ran through September. Form 4 filings dated 17 August 2026 show option exercises by President Jonathan Levin and Chief Investment Officer Frederick Pollock, with shares withheld for tax at $13.86. A director grant of 5,722 shares at $12.89 was filed 1 October 2026.

Catalysts ahead

• 1 December 2026: Record date for the $0.12 per share quarterly dividend, payable on 15 December 2026. Confirms the dividend continues; the adjusted closing prices restate downward after the ex-dividend date.
• ~10 February 2027 (est.): Fourth-quarter and full-year 2026 results. Shows whether full-year fundraising rivals 2025's $10.7 billion and whether fee-related earnings keep growing from a year earlier.

What would change the view

A weekly close below $11.50, under the 200-day moving average, which would erase the post-earnings recovery and show the market rejecting the third-quarter results. Reported fee-related earnings flat or down from a year earlier in the fourth-quarter report would also break the case.

The risks this note tracks, each with what would confirm it:

• Private-markets fee growth keeps slowing and the shrinking backlog of contracted assets limits future fees. Confirmed by: contracted not-yet-fee-paying assets below the $8.7 billion reported on 30 September 2026, or private-markets fee growth below the guided 7% to 9% in the fourth quarter.
• Fourth-quarter fundraising falls short of what a record-rivaling year requires. Confirmed by: full-year 2026 fundraising reported well below 2025's $10.7 billion in the fourth-quarter release.
• Absolute-return fee growth cools faster than the guided mid-teens rate. Confirmed by: absolute-return fee growth below the mid-teens or net outflows ending the run of inflow quarters.
• Class A supply from insiders and legacy holders continues into a thin float. Confirmed by: new SEC Form 4 or Form 144 filings showing open-market sales after the September sales at $12.59 and $13.16.
• SpaceX sales or marks reduce future performance income, or the gain converts to income unevenly. Confirmed by: further SpaceX monetization shrinking the remaining exposure of just over $3 billion, or unrealized carry falling from the record $592 million.

What it trades with

GCM Grosvenor's fee base depends on private-markets and hedge-fund fundraising conditions, the same driver behind other listed alternative asset managers. Its performance income is tied in part to the private-market value of SpaceX. At the second-quarter mark of $84 per share, management put each $10 move at about $4 million of performance fees (Earnings Whispers, 2 November 2026). The Up-C structure and thin Class A float mean unit exchanges and insider sales can move the shares regardless of market direction.